Medicine - Programa de Formación Médica Continuada Acreditado, Год журнала: 2023, Номер 13(92), С. 5452 - 5462
Опубликована: Дек. 1, 2023
Medicine - Programa de Formación Médica Continuada Acreditado, Год журнала: 2023, Номер 13(92), С. 5452 - 5462
Опубликована: Дек. 1, 2023
Pharmaceuticals, Год журнала: 2024, Номер 17(6), С. 689 - 689
Опубликована: Май 27, 2024
Public perception contrasts scientific findings on the depression-related effects of cannabis. However, earlier studies were performed when cannabis was predominantly illegal, its production mostly uncontrolled, and idea medical incipient only. We hypothesized that recent changes in attitudes legislations may have favorably affected research. In addition, publication bias against also decreased. To investigate this hypothesis, we conducted a review research published over last three years. found 156 relevant articles. most cross-sectional studies, depression higher those who consumed than did not. An increase consumption typically followed by an depression, whereas withdrawal from ameliorated cases. Although reduced none these placebo-controlled. clinical same period, placebo and, average effect size larger investigated plausibility antidepressant reviewing molecular pharmacological studies. Taken together, reviewed do not support herbal
Язык: Английский
Процитировано
0PSICUMEX, Год журнала: 2024, Номер 14, С. 1 - 34
Опубликована: Июнь 1, 2024
Los enteógenos han surgido en la investigación clínica como un tratamiento alternativo para Depresión Resistente al Tratamiento (DRT). Tienen efectos antidepresivos rápidos y duraderos, son ansiolíticos, mitigan ideación suicida. Además, inducen emociones positivas provocan experiencias místicas o espirituales, atributos que pueden contribuir a su eficacia terapéutica, dada influencia protectora del misticismo religiosidad contra depresión. Esta revisión narrativa tiene objetivo discutir evidencia existente sobre utilización de DRT, proporcionar una comprensión actualizada panorama los mecanismos acción compuestos psilocibina, DMT, LSD, ketamina, esketamina cannabinoides. La el manejo depresión ha sido validada consistentemente ensayos clínicos. No obstante, es imperativo reconocer nuestra limitada posibles adversos, especialmente largo plazo, pesar datos sustentan tolerabilidad aguda.
Процитировано
0Psychoactives, Год журнала: 2024, Номер 3(3), С. 337 - 356
Опубликована: Июль 3, 2024
Substance use/abuse and suicide are two closely related phenomena, mostly due to neurobiological, psychological, social impairments. In the present narrative review, relationship between suicidal behavior (SB) use abuse of common recreational drugs, such as alcohol, cannabis, cocaine, methamphetamine, heroin, nicotine, ketamine, psilocybin, MDMA, LSD, has been explored. Furthermore, potential mechanisms linking have also examined. According current research, all substances appear a deleterious effect on SB except for ketamine which could potentially confer protective effect. Further studies needed understand suicide.
Язык: Английский
Процитировано
0Psychiatry Research, Год журнала: 2024, Номер 339, С. 116091 - 116091
Опубликована: Июль 23, 2024
Язык: Английский
Процитировано
0Archives of Suicide Research, Год журнала: 2024, Номер unknown, С. 1 - 15
Опубликована: Июль 24, 2024
Objective To document the prevalence and correlates of suicidal ideation (SI) among individuals seeking cannabis-based medicinal products (CBMPs); to test whether SI declines or intensifies after three months CBMP treatment 12-month trajectories depression in those reporting other patients.
Язык: Английский
Процитировано
0Опубликована: Авг. 12, 2024
Язык: Английский
Процитировано
0Side effects of drugs annual, Год журнала: 2024, Номер unknown, С. 13 - 34
Опубликована: Янв. 1, 2024
Процитировано
0International Journal of Mental Health and Addiction, Год журнала: 2024, Номер unknown
Опубликована: Дек. 6, 2024
Язык: Английский
Процитировано
0JMIR Infodemiology, Год журнала: 2024, Номер unknown
Опубликована: Авг. 12, 2024
Язык: Английский
Процитировано
0Medicine - Programa de Formación Médica Continuada Acreditado, Год журнала: 2023, Номер 13(92), С. 5452 - 5462
Опубликована: Дек. 1, 2023
Процитировано
0